|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.30 USD | -2.04% |
|
-0.47% | -28.95% |
| 07-30 | Daxor Launches Blood Testing Lab in Eastern Kansis | MT |
| 07-30 | Daxor Corporation Initiates Outpatient Blood Volume Analysis Program in Kansas | CI |
Evolution of the Average Target: Daxor Corporation
Evolution of the Target Price: Daxor Corporation
Changes in Analyst Recommendations: Daxor Corporation
f5f.AoJF6U9OKxwDE1sQa6cVaj3EPXCJ7V1bXil17ufc2SU.U_MngCR3TH41WzNmL-pRGke2WQrxqzQLa0ExqKS4jW9q0TPbHyxRLFBAMA~2a23a9c6b7092203d242f6da14591761
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +8.77% | |||||
| - | - | +9.63% | |||
| Average | +9.20% | |||||
| Weighted average by Cap. | +9.15% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
10.52USD
Average target price
22.50USD
Spread / Average Target
+113.88%
High Price Target
23.00USD
Spread / Highest target
+118.63%
Low Price Target
22.00USD
Spread / Lowest Target
+109.13%
Analyst Consensus Detail
Consensus revision (last 18 months)
SellBuy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
10.52USD
Average target price
22.50USD
Spread / Average Target
+113.88%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DXR Stock
- DXR Stock
- Consensus Daxor Corporation
Select your edition
All financial news and data tailored to specific country editions
